A few studies have suggested that HER2-low tumours possess different genetic profiles compared to HER2-negative tumours, including increased expression of luminal-related genes and lower expression of tyrosine-kinase receptor genes [8,9]. The gene discussed is ERBB2; the disease is neoplasm.